Vanderbilt University Medical Center
Nashville, Tennessee, 37235, United States
NCT Number: NCT04023695
Steroid injection is the first line treatment for trigger finger. Steroid injection is sometimes mixed with a local anesthetic.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Nashville, Tennessee, 37235, United States
The treatment of trigger finger involves an injection of corticosteroid. Corticosteroid treats the underlying inflammatory pathology. Some surgeons add lidocaine with epinephrine as a local anesthetic with the injection. Lidocaine with epinephrine is associated with a burning sensation and may be the primary pain associated with the injection. We hypothesize that a corticosteroid injection without lidocaine with epinephrine will be less painful, and equally effective in treating trigger finger
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Trigger finger injection
Trigger finger injection
Time frame: Assessed 1 minute after injection (in clinic)
Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever
Time frame: Assessed after 24 hours after injection (by phone)
Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever
Vanderbilt University Medical Center
Other
Trigger Finger Corticosteroid Injection With and Without Local Anesthetic; a Randomized, Double Blind Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05032508
Muscular Diseases, Musculoskeletal Diseases
Paris, France
View Trial DetailsNCT07364695
Muscular Diseases, Musculoskeletal Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07482397
Muscular Diseases, Musculoskeletal Diseases
Toba Tek Singh, Punjab Province, Pakistan
View Trial DetailsNCT05251428
Muscular Diseases, Musculoskeletal Diseases
Atlanta, Georgia, United States
View Trial Details